Cynthia Seidel-Dugan

This inventor holds 17 USPTO granted patents and 15 published patent applications and 1 EPO patent, primarily in Cytokine Therapeutics. Top assignees: Werewolf Therapeutics, Inc., Potenza Therapeutics, Inc., Trieza Therapeutics, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cynthia Seidel-Dugan. Retrieved from https://idiyas.com/inventor/cynthia-seidel-dugan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 15)

% Patents Active = 94.1

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 49(Granted Patents)

Location History:

Belmont, CO (US) (2020)
Cambridge, MA (US) (2022)
Belmont, MA (US) (2019 - 2024)

Company Filing History:

11 out of 12

Werewolf Therapeutics, Inc.

patents

5 out of 7

Potenza Therapeutics, Inc.

patents

1 out of 1

Trieza Therapeutics, Inc.

patent

Years Active: 2019-2026

Loading Chart...

Areas of Expertise:

Cytokine Polypeptides

Interleukin-2

Interleukin-12

Antigen-Binding Proteins

Immunomodulatory Vectors

Oncolytic Adenoviral Vectors

Anti-TIGIT

Anti-Neuropilin

Anti-GITR

Separation Moieties

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617829 - ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF (2026-05-05),

2. 12275769 - Activatable interleukin 12 polypeptides and methods of use thereof (2025-04-14),

3. 12076371 - Activatable cytokine polypeptides and methods of use thereof (2024-09-03),

4. 12036266 - Activatable cytokine polypeptides and methods of use thereof (2024-07-16),

5. 11981716 - Activatable interleukin-2 polypeptides and methods of use thereof (2024-05-14),

6. 11739132 - Separation moieties and methods of use thereof (2023-08-29),

7. 11535658 - Activatable interleukin-2 polypeptides and methods of use thereof (2022-12-27),

8. 11453720 - Anti-TIGIT antigen-binding proteins and methods of use thereof (2022-09-27),

9. 11453710 - Activatable interleukin 12 polypeptides and methods of use thereof (2022-09-27),

10. 11352403 - Activatable interleukin-2 polypeptides and methods of use thereof (2022-06-07),

11. 11186644 - Anti-neuropilin antigen-binding proteins and methods of use thereof (2021-11-30),

12. 10988545 - Anti-GITR antigen-binding proteins and methods of use thereof (2021-04-27),

13. 10696724 - Activatable interleukin-2 polypeptides (2020-06-30),

14. 10696723 - Activatable interleukin 12 polypeptides (2020-06-30),

15. 10507244 - Anti-TIGIT antigen-binding proteins and methods of use thereof (2019-12-17),

Title: Cynthia Seidel-Dugan: Pioneering Inventor from Belmont, MA

Introduction: Cynthia Seidel-Dugan is a trailblazing inventor hailing from Belmont, MA, known for her innovative contributions to various fields.

Latest Patents: Cynthia Seidel-Dugan holds several patents in the areas of sustainable energy solutions, medical devices, and consumer electronics, showcasing her diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Cynthia has led groundbreaking projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout her career, Cynthia Seidel-Dugan has collaborated with top research institutions, leading companies, and talented individuals to bring her ideas to life and make a lasting impact.

Conclusion: Cynthia Seidel-Dugan's dedication to innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.